Risk of new cancers in patients with Hodgkin's disease.
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006689:Hodgkin Disease / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007109:Immunity; D007938:Leukemia / Q000209:etiology*; D007953:Leukemia, Radiation-Induced / Q000209:etiology*; D008297:Male; D009378:Neoplasms, Multiple Primary / Q000209:etiology* / Q000276:immunology; D009381:Neoplasms, Radiation-Induced / Q000209:etiology*
D000970:Antineoplastic Agents